2025-2031 Global Mesalamine Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > 2025-2031 Global Mesalamine Industry Research & Trends Analysis Report

2025-2031 Global Mesalamine Industry Research & Trends Analysis Report

Publication Date: 2025-09-18
Report Id: 2404948
Industry: Pharma & Healthcare
Report Page: 139
Chart: 140

PDF Download

Publication Date: 2025-09-18
Report Id: 2404948
Industry: Pharma & Healthcare
Report Page: 139
Chart: 140

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Mesalamine Definition
1.2 Global Mesalamine Market Size and Forecast
1.2.1 By Revenue, Global Mesalamine Market Size, 2020-2031
1.2.2 By Sales Volume, Global Mesalamine Market Size, 2020-2031
1.2.3 Global Mesalamine Price Trend, 2020-2031
1.3 China Mesalamine Market Size and Forecast
1.3.1 By Revenue, China Mesalamine Market Size, 2020-2031
1.3.2 By Sales Volume, China Mesalamine Market Size, 2020-2031
1.3.3 China Mesalamine Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Mesalamine Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Mesalamine Share in Global Market, 2020-2031
1.4.3 Mesalamine Market Size: China VS Global, 2020-2031
1.5 Mesalamine Market Dynamics
1.5.1 Mesalamine Market Drivers
1.5.2 Mesalamine Market Restraints
1.5.3 Mesalamine Industry Trends
1.5.4 Mesalamine Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Mesalamine Revenue by Company, 2020-2025
2.2 Global Mesalamine Sales Volume by Company, 2020-2025
2.3 Global Mesalamine Price by Company, 2020-2025
2.4 Global Mesalamine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Mesalamine Concentration Ratio
2.6 Global Mesalamine Mergers & Acquisitions, Expansion Plans
2.7 Global Mesalamine Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Mesalamine Revenue by Company, 2020-2025
3.2 China Mesalamine Sales Volume by Company, 2020-2025
3.3 China Mesalamine Mesalamine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Mesalamine Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Mesalamine Domestic VS Export
3.6 China Market, Mesalamine Import & Export
3.6.1 China Market, Mesalamine Import & Export, 2020-2031
3.6.2 China Mesalamine Import & Export Trends
3.6.3 Main Sources of China Mesalamine Import
3.6.4 Export Destination of China Mesalamine

4 Mesalamine Production by Region
4.1 Global Mesalamine Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Mesalamine Manufacturers
4.3 Global Major Manufacturers, Mesalamine Capacity Expansion and Future Plans
4.4 Global Mesalamine Capacity by Region
4.5 Global Mesalamine Production by Region
4.5.1 Global Mesalamine Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Mesalamine Production by Region, 2020-2025
4.5.3 Global Mesalamine Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Mesalamine Industry Chain
5.2 Mesalamine Upstream Analysis
5.2.1 Mesalamine Core Raw Materials
5.2.2 Main Manufacturers of Mesalamine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Mesalamine Production Mode
5.6 Mesalamine Procurement Model
5.7 Mesalamine Industry Sales Model and Sales Channels
5.7.1 Mesalamine Sales Model
5.7.2 Mesalamine Typical Distributors

6 Sights by Type
6.1 Mesalamine Classification by Type
6.1.1 Purity ≥ 97%
6.1.2 Purity ≥ 98%
6.1.3 Purity ≥ 99%
6.2 by Type, Global Mesalamine Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Mesalamine Revenue, 2020-2031
6.4 by Type, Global Mesalamine Sales Volume, 2020-2031
6.5 by Type, Global Mesalamine Price, 2020-2031

7 Sights by Application
7.1 Mesalamine Segment by Application
7.1.1 Tablets
7.1.2 Capsules
7.1.3 Granule
7.1.4 Suppository
7.1.5 Enema
7.1.6 Others
7.2 by Application, Global Mesalamine Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Mesalamine Revenue, 2020-2031
7.4 by Application, Global Mesalamine Sales Volume, 2020-2031
7.5 by Application, Global Mesalamine Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Mesalamine Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Mesalamine Revenue, 2020-2031
8.3 By Region, Global Mesalamine Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Mesalamine Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Mesalamine Market Size Market Share
8.5 Europe
8.5.1 Europe Mesalamine Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Mesalamine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Mesalamine Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Mesalamine Market Size Market Share
8.7 South America
8.7.1 South AmericaMesalamine Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Mesalamine Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Mesalamine Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Mesalamine Revenue, 2020-2031
9.3 By Country, Global Mesalamine Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Mesalamine Market Size, 2020-2031
9.4.2 By Company, United States Mesalamine Sales Volume Market Share, 2024
9.4.3 by Type, United States Mesalamine Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Mesalamine Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Mesalamine Market Size, 2020-2031
9.5.2 By Company, Europe Mesalamine Sales Volume Market Share, 2024
9.5.3 by Type, Europe Mesalamine Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Mesalamine Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Mesalamine Market Size, 2020-2031
9.6.2 By Company, China Mesalamine Sales Volume Market Share, 2024
9.6.3 by Type, China Mesalamine Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Mesalamine Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Mesalamine Market Size, 2020-2031
9.7.2 By Company, Japan Mesalamine Market Share, 2024
9.7.3 by Type, Japan Mesalamine Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Mesalamine Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Mesalamine Market Size, 2020-2031
9.8.2 By Company, South Korea Mesalamine Market Share, 2024
9.8.3 by Type, South Korea Mesalamine Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Mesalamine Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Mesalamine Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Mesalamine Market Share, 2024
9.9.3 by Type, Southeast Asia Mesalamine Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Mesalamine Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Mesalamine Market Size, 2020-2031
9.10.2 By Company, India Mesalamine Market Share, 2024
9.10.3 by Type, India Mesalamine Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Mesalamine Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Mesalamine Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Mesalamine Market Share, 2024
9.11.3 by Type, Middle East & Africa Mesalamine Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Mesalamine Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 PharmaZell
10.1.1 PharmaZell Company Information, Head Office, Market Area, and Industry Position
10.1.2 PharmaZell Mesalamine Models, Specifications, and Application
10.1.3 PharmaZell Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 PharmaZell Company Profile and Main Business
10.1.5 PharmaZell Recent Developments
10.2 Syntese A/S
10.2.1 Syntese A/S Company Information, Head Office, Market Area, and Industry Position
10.2.2 Syntese A/S Mesalamine Models, Specifications, and Application
10.2.3 Syntese A/S Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Syntese A/S Company Profile and Main Business
10.2.5 Syntese A/S Recent Developments
10.3 Cambrex Corporation
10.3.1 Cambrex Corporation Company Information, Head Office, Market Area, and Industry Position
10.3.2 Cambrex Corporation Mesalamine Models, Specifications, and Application
10.3.3 Cambrex Corporation Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Cambrex Corporation Company Profile and Main Business
10.3.5 Cambrex Corporation Recent Developments
10.4 Divis Laboratories
10.4.1 Divis Laboratories Company Information, Head Office, Market Area, and Industry Position
10.4.2 Divis Laboratories Mesalamine Models, Specifications, and Application
10.4.3 Divis Laboratories Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Divis Laboratories Company Profile and Main Business
10.4.5 Divis Laboratories Recent Developments
10.5 Chemi SpA
10.5.1 Chemi SpA Company Information, Head Office, Market Area, and Industry Position
10.5.2 Chemi SpA Mesalamine Models, Specifications, and Application
10.5.3 Chemi SpA Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Chemi SpA Company Profile and Main Business
10.5.5 Chemi SpA Recent Developments
10.6 Ipca Laboratories
10.6.1 Ipca Laboratories Company Information, Head Office, Market Area, and Industry Position
10.6.2 Ipca Laboratories Mesalamine Models, Specifications, and Application
10.6.3 Ipca Laboratories Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 Ipca Laboratories Company Profile and Main Business
10.6.5 Ipca Laboratories Recent Developments
10.7 Hangzhou Brother
10.7.1 Hangzhou Brother Company Information, Head Office, Market Area, and Industry Position
10.7.2 Hangzhou Brother Mesalamine Models, Specifications, and Application
10.7.3 Hangzhou Brother Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Hangzhou Brother Company Profile and Main Business
10.7.5 Hangzhou Brother Recent Developments
10.8 Lianyungang Fengheng Biopharm
10.8.1 Lianyungang Fengheng Biopharm Company Information, Head Office, Market Area, and Industry Position
10.8.2 Lianyungang Fengheng Biopharm Mesalamine Models, Specifications, and Application
10.8.3 Lianyungang Fengheng Biopharm Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.8.4 Lianyungang Fengheng Biopharm Company Profile and Main Business
10.8.5 Lianyungang Fengheng Biopharm Recent Developments
10.9 Lasa Loboratory
10.9.1 Lasa Loboratory Company Information, Head Office, Market Area, and Industry Position
10.9.2 Lasa Loboratory Mesalamine Models, Specifications, and Application
10.9.3 Lasa Loboratory Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Lasa Loboratory Company Profile and Main Business
10.9.5 Lasa Loboratory Recent Developments
10.10 Corden Pharma Bergamo
10.10.1 Corden Pharma Bergamo Company Information, Head Office, Market Area, and Industry Position
10.10.2 Corden Pharma Bergamo Mesalamine Models, Specifications, and Application
10.10.3 Corden Pharma Bergamo Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.10.4 Corden Pharma Bergamo Company Profile and Main Business
10.10.5 Corden Pharma Bergamo Recent Developments
10.11 Erregierre SpA
10.11.1 Erregierre SpA Company Information, Head Office, Market Area, and Industry Position
10.11.2 Erregierre SpA Mesalamine Models, Specifications, and Application
10.11.3 Erregierre SpA Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.11.4 Erregierre SpA Company Profile and Main Business
10.11.5 Erregierre SpA Recent Developments
10.12 CTX Lifescience
10.12.1 CTX Lifescience Company Information, Head Office, Market Area, and Industry Position
10.12.2 CTX Lifescience Mesalamine Models, Specifications, and Application
10.12.3 CTX Lifescience Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.12.4 CTX Lifescience Company Profile and Main Business
10.12.5 CTX Lifescience Recent Developments
10.13 Ishita Active Pharma Ingredients
10.13.1 Ishita Active Pharma Ingredients Company Information, Head Office, Market Area, and Industry Position
10.13.2 Ishita Active Pharma Ingredients Mesalamine Models, Specifications, and Application
10.13.3 Ishita Active Pharma Ingredients Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.13.4 Ishita Active Pharma Ingredients Company Profile and Main Business
10.13.5 Ishita Active Pharma Ingredients Recent Developments
10.14 YC Biotech (Jiangsu)
10.14.1 YC Biotech (Jiangsu) Company Information, Head Office, Market Area, and Industry Position
10.14.2 YC Biotech (Jiangsu) Mesalamine Models, Specifications, and Application
10.14.3 YC Biotech (Jiangsu) Mesalamine Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.14.4 YC Biotech (Jiangsu) Company Profile and Main Business
10.14.5 YC Biotech (Jiangsu) Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Mesalamine should grow from US$ 202 million in 2024 to US$ 258 million by 2031, with a CAGR of 3.9% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Mesalamine

According to YH Research, the global market for Mesalamine should grow from US$ 202 million in 2024 to US$ 258 million by 2031, with a CAGR of 3.9% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Mesalamine also known as mesalazine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.

In 2024, global Mesalamine sales reached approximately 5,417 tons, with an average global market price of around US$ 35.0 per kg.

The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.

With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.

Global key players of Mesalamine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalamine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.

This report aims to provide a comprehensive study of the global market for Mesalamine.
Report Highlights:
(1) Global Mesalamine market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Mesalamine market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Mesalamine market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Mesalamine segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Mesalamine segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Mesalamine, capacity, production and trends.

(7) Mesalamine industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Purity ≥ 97%
Purity ≥ 98%
Purity ≥ 99%

Market segment by Application, can be divided into
Tablets
Capsules
Granule
Suppository
Enema
Others

Market segment by players, this report covers
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)